|Articles|December 15, 2015
PerkinElmer Launches Clinical Data Review Solution
The solution identifies unknown relationships in data, whereby customers can perform dimension-free exploratory analysis on data such as adverse events, labs, concomitant medications, medical history and vital signs.
Advertisement
Perkin Elmer launched its Clinical Data Review solution that is built on TIBCO Spotfire® analytics platform. It allows for identification of unknown relationships in data, whereby customers can perform dimension-free exploratory analysis on data such as adverse events, labs, concomitant medications, medical history and vital signs. With contextual collaboration, clinicians and data management can quickly identify data quality issues and perform adaptive monitoring.
Read the full
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced
2
Breaking the Efficacy Ceiling in IBD and Beyond
3
ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps
4
Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV
5